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vaccine chart of patients with rheumatic disorders. In addition, 
knowing that the speci¿ c prescription of vaccines during the 
clinical follow-up of those patients has a positive impact on the 
increase of vaccine coverage, work groups of specialists have 
been formed to establish vaccine guidelines in rheumatology, 
reÀ ecting an increasing concern worldwide in recent years.8,9
The Rheumatoid Arthritis Committee of the Brazilian 
Society of Rheumatology has developed the consensus 
published in this journal10 aimed at summarizing the recom-
mendations for vaccinating patients with RA, considering the 
epidemiological scenario of endemic diseases in Brazil, such as 
yellow fever. Thus, the 2012 Brazilian Society of Rheumatology 
Consensus on vaccination of patients with rheumatoid arthritis 
was aimed at standardizing and encouraging the indication of 
immunization by rheumatologists and other professionals who 
manage those patients.
Finally, we believe that the implementation of those rec-
ommendations is perfectly feasible in Brazil. Therefore, it is 
fundamental to promote continuous medical education and 
patients’ instruction, and to review the subject periodically, so 
that an updated approach based on scienti¿ c evidence can be 
incorporated into clinical practice.
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In the city of Rio de Janeiro, at the beginning of the 20th century, the physician Oswaldo Cruz, a Brazilian science pioneer, conducted the ¿ rst vaccination campaign in Brazil.1 
In his ¿ ght to promote mass vaccination against smallpox, the 
sanitarian faced innumerous obstacles, such as the population’s 
ignorance about the vaccine and a ¿ erce political opposition 
originated from several sectors of the society, including his 
medical colleagues. The dissemination of rumors against the 
vaccine collaborated with the almost total lack of adhesion of the 
population of the city of Rio de Janeiro to the vaccination cam-
paign. That, along with several protests against the government, 
generated a social convulsion that culminated with the Vaccine 
Revolt, a true urban battle with dozens of deaths and hundreds 
of wounded people. Thousands of other victims of the Vaccine 
Revolt would appear in the following years, with the suspension 
of obligatory vaccination and advance of the epidemic. 
More than 100 years after the Oswaldo Cruz’s initiative, the 
lessons learned over the decades led to the development of a suc-
cessful and internationally recognized immunization program 
in Brazil. However, a signi¿ cant part of the population with 
chronic inÀ ammatory diseases, despite being more susceptible 
to infections, still remains unprotected.2,3 That is the case of 
patients with rheumatoid arthritis (RA).
Based on the current scienti¿ c knowledge, one can state that 
patients with RA, in addition to being at higher risk for infec-
tions,4 have an increased infection-related mortality, up to ten 
times that of the general population.5 Of the factors implicated in 
the susceptibility to infections, the earlier and more intense ex-
posure to immunosuppressive drugs and biologics stands out.6,7
Considering that vaccination is the preventive measure 
with the greatest impact on reducing the occurrence of infec-
tion at any age group, it is mandatory to review and update the 
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